MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
73 hedge funds and large institutions have $96.8M invested in Merrimack Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
80% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 55
Holders
73
Holding in Top 10
–
Calls
$553K
Puts
$56K
Top Buyers
| 1 | +$5.67M | |
| 2 | +$4.91M | |
| 3 | +$945K | |
| 4 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
+$623K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$473K |
Top Sellers
| 1 | -$2.08M | |
| 2 | -$1.65M | |
| 3 | -$1.01M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$771K |
| 5 |
Morgan Stanley
New York
|
-$494K |